Pernix Therapeutics generics news

Pernix reduced its combined sales headcount by about 62 (33%) to about 125 following the integration of generics company Cypress Pharmaceutical Inc. and its Hawthorn Pharmaceuticals Inc. branded pharmaceutical subsidiary. Pernix said the sales force will remain focused on pediatrics, primary care and gastroenterology (see BioCentury, Jan. 7). ...